Alaunos Therapeutics (TCRT) Other Accumulated Expenses (2011 - 2022)
Alaunos Therapeutics (TCRT) reported Other Accumulated Expenses of $169000.0 for Q4 2022, up 1.2% on a YoY basis from $167000.0 in Q4 2021, and up 1.2% quarter-over-quarter from $167000.0 in Q4 2021.
Alaunos Therapeutics (TCRT) Other Accumulated Expenses (2011 - 2022) Analysis & Trends
Alaunos Therapeutics has reported Other Accumulated Expenses for 9 years, with the latest figure at $169000.0 in Q4 2022.
- For the quarter ending Q4 2022, Other Accumulated Expenses rose 1.2% year-over-year to $169000.0; the trailing twelve-month figure through Dec 2022 stood at $169000.0 (up 1.2% YoY), and the FY2022 full-year result was $169000.0, up 1.2% from the prior year.
- Other Accumulated Expenses for Q4 2022 stood at $169000.0, up from $167000.0 in the prior quarter.
- The five-year high for Other Accumulated Expenses was $169000.0 in Q4 2022, with the low at $167000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Alaunos Therapeutics | 4.31 Mn | 3.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 169,000.00 |
| Dec 31, 2021 | 167,000.00 |
| Dec 31, 2017 | 222,000.00 |
| Dec 31, 2016 | 28,000.00 |
| Dec 31, 2015 | 66,000.00 |
| Dec 31, 2014 | 226,000.00 |
| Dec 31, 2013 | 230,000.00 |
| Dec 31, 2012 | 903,000.00 |
| Dec 31, 2011 | 347,000.00 |